Highlight

STAT News: Arrakis' lofty goal: Kill cancer with pills that target RNA instead of proteins

The startup is trying to achieve a feat once thought to be biotech fantasy: Develop oral medicines - pills - that can target RNA, the...
Highlight

Forbes: Is Silicon Valley coming for rosé?

Bev, a female-focused beverage company disrupting the male-dominated alcohol industry, has raised $7 million.
Highlight

Reuters: Aeva signs sensor deal with Audi's self-driving unit

Aeva has signed a sensor-system deal with an Audi-owned unit that is working on self-driving technology for Volkswagen AG.
Highlight

Business Insider: Nocion raises $27M to make a new kind of painkiller as the race to replace opioids heats up

As America grapples with a deadly opioid epidemic, there's a desperate need for better, non-addictive painkillers. Using science out of Harvard and...
Highlight

Vogue: How sustainable Is consigning clothing? The RealReal is glad you asked

To help publicize the sustainability of consigning clothing and participating in a circular economy, The RealReal has rolled out its first...
Highlight

Bloomberg: SoftBank backs ClimaCell, startup pioneering hyper-accurate weather reports

SoftBank is investing $7M in ClimaCell, a weather startup that combines traditional forecasting with wireless signals, street cameras, drones and...
Highlight

Joydeep Bhattacharyya promoted to General Partner

We are thrilled to share that Joydeep Bhattacharyya has been promoted to General Partner at Canaan.
Highlight

Crunchbase: Spark Networks swipes right for SF dating company Zoosk

Spark Networks plans to acquire San Francisco’s Zoosk, making it the second largest online dating platform in North America. Spark Networks valued...
Highlight

SaaS portfolio momentum

The companies that make up our SaaS portfolio have shown some incredible momentum over the last 18 months. Here’s a bit about what they’ve been up to.
Highlight

Nature: Protein-slaying drugs could be the next blockbuster therapies

Researchers at Arvinas are hijacking the cell’s protein-disposal system in the fight against Alzheimer’s and intractable cancers.
Highlight

VentureBeat: Forte and Ripple form $100M fund for mainstream blockchain games

Blockchain gaming startup Forte has announced a big deal with Ripple’s Xpring cryptocurrency platform to invest $100 million in game developers who...
Highlight

Bloomberg: A new Honda for almost nothing? Car sharing becomes a sales tool

Turo, the Airbnb-like service for autos, is helping consumers afford ever-pricier new cars.
Highlight

Vogue: Meet Tia, the new women’s clinic making gynecologist visits less stressful

The Tia Clinic, located in New York’s Flatiron neighborhood, is supporting wellness with timely holistic health care that intends to take the...
Highlight

Endpoints News: Canaan leaps into UK biotech, co-leading $14M Series A for upstart Grey Wolf

Grey Wolf Therapeutics is working on a fresh approach to immuno-oncology that does not directly target the immune system, but instead alters tumor...
Highlight

The New York Times: Tycoon of the pre-owned

Can Silicon Valley survivor Julie Wainwright’s luxury consignment company, The RealReal, save retail?
Highlight

Bloomberg: Facebook acquires GrokStyle, visual shopping startup, to bolster AI work

Facebook could use the underlying AI technology and GrokStyle’s employees to bolster its own efforts in the field.
Highlight

Michael Gilroy: Announcing the Beam Team and their Series A

Money laundering – and regulator fines – are expensive pain points for the financial industry. Legacy monitoring systems just haven't cut it,...
Highlight

Laura Chau: A new way to party – with Coterie

Dozens of industries have been re-thought with the experience-driven, millennial customer in mind. The next business that's ripe for...
Highlight

Rayfe Gaspar-Asaoka: The shift to an 80/20 robot-first world

Today’s biggest industries largely follow the 80/20 rule of 80% manual and 20% automated. However, in tomorrow’s world that 80/20 will flip, and...
Highlight

Laura Chau: A prescription for how the healthcare industry can spark joy

Much of healthcare is sorely lacking on the “joy” front. Here are three takeaways that healthcare innovators can channel to “spark joy” and capture...
Highlight

SF Business Times: Antiva CEO draws on personal experience to fuel drug development

Gail Maderis, President & CEO of Antiva, knows how to shape and lead people to get results.
Highlight

Michael Gilroy promoted to Partner

We are excited to share that Michael Gilroy has been promoted to Partner.
Highlight

Joydeep Bhattacharyya: Our investment in Dragos

I am delighted to announce our Series B investment in Dragos, a pioneer in the fast emerging Industrial Control Systems (ICS) Security market.
Highlight

Businessweek: These robots help Amazon’s competitors narrow the delivery gap

Berkshire Grey’s machines can pick, pack and ship most items of 5 pounds or less.
Highlight

Rayfe Gaspar-Asaoka: The safest car you will never drive

Autonomous vehicles (AVs) are coming. The question is no longer if, but rather where we are along the adoption curve across various use cases and...
Highlight

Forbes: Three Canaan investors named to Forbes' 30 under 30

We are so proud of these three rising stars -- Adina Tecklu, Hootie Rashidifard and Laura Chau -- for being named to Forbes’ 30 under 30!
Highlight

Forbes: Ex-Apple engineers raise $45MM For ‘generational leap’ vision tech for robot cars

Autonomous technology has many hurdles to clear before it's ubiquitous, including better and cheaper vision. Aeva claims to have a next-generation...
Highlight

Nasdaq: Cancer biotech Arvinas prices upsized IPO at $16

Arvinas, a preclinical biotech developing protein degradation therapies for advanced cancers, raised $120 million by offering 7.5 million shares at...
Highlight

NYT: Get in bed with Skynet and Bumblebee Spaces

Robot furniture is happening with Bumblebee Spaces. This is the single greatest thing to happen to humanity ever, the robots told us to say.
Highlight

Maha Ibrahim & Dan Ciporin: Next generation investors for next generation entrepreneurs

A new generation of entrepreneur is building consumer products and services - ideas that seem crazy today, and will feel intuitive in a few years....
Highlight

STAT News: Antiva tried to drum up interest for a much-needed drug. Many men didn’t get it

Antiva is working on a first-in-class treatment that, if successful, could make surgery for precancerous cervical lesions caused by the human...
Highlight

Bloomberg: World View wants to send you to the stratosphere in a balloon

World View has figured out how to keep a capsule stable 100,000 feet above the Earth. Interested in a ride?
Highlight

Announcing ScaleFactor: Automated financial operations platform built for Main Street

We're investing in ScaleFactor, a company focused on empowering small businesses to easily make the best strategic and financial decisions so they...
Highlight

Adina Tecklu & Hootie Rashidifard: Canaan Beta for alpha

We’re excited to be launching Canaan Beta, Canaan’s new $20 million seed program that aims to invest in the next wave of consumer technologies...
Highlight

Nina Kjellson: "Jumping together" to move the field of personalized cancer therapy

We at Canaan are “all in” on the notion that diversity of knowledge and experience breeds the best results. With this as our core value, PACT...
Highlight

Dan Ciporin: Ownership -- a big idea to transform the current brand-loyalty model

How far have loyalty programs come in actually cultivating true loyalty from consumers, as opposed to just transactions? Introducing our newest...
Highlight

Rich Boyle: Enjoying an AI summer

It's been decades in the making, but the current AI summer is going to be a long one. Read more from AI industry veteran and investor, Rich Boyle...
Highlight

Tim Shannon: More hope for cystic fibrosis treatment, and still more to do

The progress made in the treatment of CF is shows what can happen when research, policy, advocacy and investment align toward a common goal. But...
Highlight

The next generation of computation

Professor Robert Schoelkopf of QCI inside a lab at Yale University. Photo Credit: Roger Kisby for The New York Times
Highlight

The New Yorker: The RealReal’s radical vision of secondhand luxury

An inside look at how The RealReal is redefining consignment for its 8 million members (and counting).
Highlight

Spotlight on Wende Hutton’s 25 years in venture capital

General Partner Wende Hutton is an industry pioneer. Partner Julie Grant chatted with Wende about today’s scientific renaissance, the importance of...
Highlight

Video: Introducing The Makers, featuring Dan Ciporin & Amir Ashkenazi

The Makers is a new Canaan content series featuring entrepreneur and investor insights into company-building.
Highlight

Nina Kjellson: A critical marriage for science and health tech

The prehistoric nature of health IT isn’t just a nuisance. It will literally determine whether patients and physicians can realize the potential of...
Highlight

What home is

Meet our newest investment Homeis. A new kind of social network that connects foreign born locals with one another, and their roots.
Highlight

What's Rarer than a Unicorn in Silicon Valley? A Female VC.

Canaan Associate Laura Chau reflects on the 3 major takeaways she's learned from women in venture capital
Highlight

IDEAYA & the Next Frontier in Synthetic Lethality

WSJ: Ideaya Biosciences Collects $94 Million for Cancer Therapy
Highlight

The Roadmap for Board Diversity

Diversity is not window dressing. It is a positive predictor of performance and governance.
Highlight

Built to Last

Excited to share news about our new $800 million fund. We know what works and we're sticking to it with our diversified, early stage approach.
Highlight

World View

New York Times: A chicken sandwich hitches a balloon ride to the stratosphere.
Highlight

Spotlight: Q&A with Rich Boyle

Get to know our newest GP and longtime startup operator Rich Boyle. Word to the wise: don't throw the term AI around with him unless you mean it.
Highlight

Annum

Heavy drinking is the largest ignored epidemic in the U.S. There is a superior alternative to rehab.
Highlight

Body Politic Series: Women's access to healthcare

The first installment of this series couldn't have been more timely.
Highlight

Protagonist Therapeutics

A simple promise: replacing injections with pills.